Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Donald A Mahler, Henrik Watz, Rachel Emerson-Stadler, John Ritz, Asparuh Gardev, Asif Shaikh & M Bradley Drummond. (2023) Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1729-1740.
Read now
Read now
Varsha Komalla, Chun Yuen Jerry Wong, Imco Sibum, Bernhard Muellinger, Wietze Nijdam, Vishal Chaugule, Julio Soria, Hui Xin Ong, Nicolas A. Buchmann & D. Traini. (2023) Advances in soft mist inhalers. Expert Opinion on Drug Delivery 20:8, pages 1055-1070.
Read now
Read now
Donald A Mahler, Andrea Ludwig-Sengpiel, Gary T Ferguson, Alberto de la Hoz, John Ritz, Asif Shaikh & Henrik Watz. (2021) TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2455-2465.
Read now
Read now
Anne Tschacher, Cordula Cadus, Sebastian Schildge, Jens Peter Diedrich, Prashant N. Chhajed, Anne B. Leuppi-Taegtmeyer & Jörg Daniel Leuppi. (2021) Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland. Current Medical Research and Opinion 37:11, pages 2019-2033.
Read now
Read now
Andrea S. Melani. (2021) Inhaler technique in asthma and COPD: challenges and unmet knowledge that can contribute to suboptimal use in real life. Expert Review of Clinical Pharmacology 14:8, pages 991-1003.
Read now
Read now
Anna-Maria Ciciliani, Mark Denny, Peter Langguth, Thomas Voshaar & Herbert Wachtel. (2021) Lung Deposition Using the Respimat® Soft Mist™ Inhaler Mono and Fixed-Dose Combination Therapies: An In Vitro/In Silico Analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:1, pages 91-100.
Read now
Read now
Mario Cazzola, Francesco Cavalli, Omar S. Usmani & Paola Rogliani. (2020) Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Delivery 17:5, pages 635-646.
Read now
Read now
Roland Buhl, Michael Dreher, Stephanie Korn, Christian Taube, Christian Stock, Christoph M Zehendner, Anke Kondla & Claus F Vogelmeier. (2020) A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Study Protocol. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2601-2608.
Read now
Read now
Articles from other publishers (11)
Christian Witt & Uta Liebers. (2023) Der ambulante pneumologische Patient in Zeiten zunehmender globaler ErwärmungOutpatient management of lung diseases in times of increasing global warming. Zeitschrift für Pneumologie 20:3, pages 144-151.
Crossref
Crossref
R. de Simón Gutiérrez, L. Ginel Mendoza, A. Hidalgo Requena, D. Rico Munilla & F. Cantalapiedra Fernández. (2022) ¿Desechan correctamente los pacientes sus dispositivos de inhalación? Proyecto AIRE. Medicina de Familia. SEMERGEN 48:1, pages 14-22.
Crossref
Crossref
Vilma Rossi, Johanna Salimäki, Charlotta Sandler, Marja Airaksinen & Paula Kauppi. (2021) Effectiveness of inhalation technique assessment service for patients with Respimat® inhaler. Pulmonary Pharmacology & Therapeutics 71, pages 102077.
Crossref
Crossref
Michael Dreher, David Price, Asparuh Gardev, Pascale Peeters, Satish Arora, Simone van der Sar – van der Brugge, Richard Dekhuijzen & Omar S Usmani. (2021)
Patient perceptions of the re-usable Respimat
®
Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study
. Chronic Respiratory Disease 18, pages 147997312098622.
Crossref
Crossref
Christian Taube, Valentina Bayer, Christoph Michael Zehendner & Arschang Valipour. (2020) Assessment of Patient Experiences with Respimat® in Everyday Clinical Practice. Pulmonary Therapy 6:2, pages 371-380.
Crossref
Crossref
Peter Nickolaus, Birgit Jung, Juan Sabater, Samuel Constant & Abhya Gupta. (2020) Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis. ERJ Open Research 6:4, pages 00429-2020.
Crossref
Crossref
Hana Douafer, Véronique Andrieu & Jean Michel Brunel. (2020) Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases. Journal of Controlled Release 325, pages 276-292.
Crossref
Crossref
Gustaf Ortsäter, Fredrik Borgström, Mike Baldwin & Carolin Miltenburger. (2019) Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT® Re-usable Inhaler. Applied Health Economics and Health Policy 18:3, pages 433-442.
Crossref
Crossref
Tien-Pei Fang, Yu-Ju Chen, Tsung-Ming Yang, Szu-Hu Wang, Ming-Szu Hung, Shu-Hua Chiu, Hsin-Hsien Li, James B. Fink & Hui-Ling Lin. (2020) Optimal Connection for Tiotropium SMI Delivery through Mechanical Ventilation: An In Vitro Study. Pharmaceutics 12:3, pages 291.
Crossref
Crossref
Gustaf Ortsäter, Fredrik Borgström, Stéphane Soulard & Carolin Miltenburger. (2019) A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT® Re-usable in the Nordics and Benelux. Advances in Therapy 36:12, pages 3435-3445.
Crossref
Crossref
Hannah A. Blair. (2019) Tiotropium/Olodaterol: A Review in COPD. Drugs 79:9, pages 997-1008.
Crossref
Crossref